Bioactivity guided isolation and structural characterization of the antidiabetic and antioxidant compound from bark extract of Avicennia officinalis Lopen access
- Authors
- Das, S. K.; Samantaray, D.; Sahoo, S. K.; Patra, J. K.; Samanta, L.; Thatoi, H.
- Issue Date
- Sep-2019
- Publisher
- ELSEVIER
- Keywords
- Avicennia officinalis; Antidiabetic; Antioxidant; Bioactivity guided assay; GC-MS analysis
- Citation
- SOUTH AFRICAN JOURNAL OF BOTANY, v.125, pp 109 - 115
- Pages
- 7
- Indexed
- SCIE
SCOPUS
- Journal Title
- SOUTH AFRICAN JOURNAL OF BOTANY
- Volume
- 125
- Start Page
- 109
- End Page
- 115
- URI
- https://scholarworks.dongguk.edu/handle/sw.dongguk/7738
- DOI
- 10.1016/j.sajb.2019.07.011
- ISSN
- 0254-6299
1727-9321
- Abstract
- The present study was aimed at evaluating the antidiabetic activity of the ethanol bark extract of a mangrove plant Avicennia officinalis (AOEB) in streptozotocin (STZ)-induced diabetic mice. The study revealed AOEB could lower the blood glucose level significantly (p < .05) in diabetic mice at dose of 200 mg/kg b.w. The elevated total cholesterol, triglyceride, liver toxicity makers (SGOT and SGPT) and urea level were found to be ameliorated. The in vitro bioactivity-guided assay of AOEB led to isolation of a bioactive compound that inhibits the carbohydrate metabolizing enzymes (alpha-amylase and alpha-glucosidase) and also scavenging the DPPH, ABTS and superoxide radicals. The structure of the isolated compound was analyzed by different spectral techniques as FT-IR, CHNS, H-1 NMR, C-13 NMR, MS. Further, the isolated compound was analyzed by HPLC. However, further studies are required to elucidate the exact structure of the isolated compound. (C) 2019 SAAB. Published by Elsevier B.V. All rights reserved.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Life Science and Biotechnology > ETC > 1. Journal Articles

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.